News
The ′Osteochip Project′ involded more than 1,700 post-menopause women aged 45 and older from France, Switzerland and Italy. This study is being developed by Bioiberica Farma, a leading Spanish biotechnology company with more than 30 years of experience in joint care under its belt. Dr.
Nearly 17% of the Andalusian population suffers from osteoarthritis, a disease that causes 35% of primary care visitsExperts will meet next Thursday in Malaga to discuss this disease and the role that pharmacists can play in monitoring its development
It was held on November 22nd, 2012 at the Faculty of Pharmacy of the Universidad de La Laguna, with some 200 healthcare professionals in attendance. There were discussed the most relevant aspects of treatments and its pharma-economics assessment, as well as the latest research news
Healthcare professionals from different areas of expertise will attend next Friday, November 30th, the 2nd conference of Clinical Rheumatology of the Spanish Society of Familial and Community Medicine. It will be held at the Meliá Lebreros Hotel in Seville, Spain.
According to the president of the International Union of Pharmacy (IUPHAR), Professor Patrick du Souich, from the University of Montreal, widespread use of that drug could bring important improvements to the life quality of OA patients, as well as significant reduction costs for our national healthcare servicesAlong the same lines, Professor Jean- Pierre Pelletier, from the University of Montre